Register
Login:
Share:
Email Facebook Twitter


ASCENT RESOURCES: Gas flows mean cash flows to develop up to 15 wells


Reneuron Share Price (RENE)



Share Price Information for Reneuron (RENE)


Share Price: 1.975Bid: 1.95Ask: 2.00Change: 0.00 (0.00%)No Movement on Reneuron
Spread: 0.05Spread as %: 2.56%Open: 2.05High: 2.05Low: 1.95Yesterday’s Close: 1.975

Reneuron Group Plc Ord 1P

Reneuron is listed in the FTSE AIM All-Share
Reneuron is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
1.975

Share Price SpacerBid
1.95

Share Price SpacerAsk
2.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
1,706,887

Share Price SpacerOpen
2.05

Share Price SpacerHigh
2.05

Share Price SpacerLow
1.95

Share Price SpacerClose
1.975

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 3,164.62m £62.50m 100,000

52 Week High 3.50 52 Week High Date 5-DEC-2016
52 Week Low 1.58 52 Week Low Date 18-SEP-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
15 601,511 607,170 -3.950 -0.50 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

17-Nov-17
16:23:48
2.00
49,412
Buy* 
1.90
2.00
988.24
Trade Type:
Ordinary

17-Nov-17
16:19:56
1.977
25,000
Buy* 
1.90
2.00
494.25
Trade Type:
Ordinary

17-Nov-17
14:40:03
1.9749
250,000
Buy* 
1.90
2.00
4,937
Trade Type:
Ordinary




View more Reneuron trades >>

Directors Deals for Reneuron (RENE)
Trade DateActionNotifierPriceCurrencyAmountHolding
07-Feb-17Buy
Trade Notifier Information for ReNeuron Group
Michael Hunt held the position of CFO at ReNeuron Group at the time of this trade.
 Michael Hunt
2.64GBX250,0002008471
31-Mar-16Notification of Holding
Trade Notifier Information for ReNeuron Group
Simon Christopher Cartmell held the position of Non-Executive Director at ReNeuron Group at the time of this trade.
 Simon Christopher Cartmell
00787500
31-Mar-16Notification of Holding
Trade Notifier Information for ReNeuron Group
Timothy (Tim) Corn held the position of Non-Executive Director at ReNeuron Group at the time of this trade.
 Timothy (Tim) Corn
00200000
View more Reneuron directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Thu 07:56Fredd1eboyRE: Exosomes c/o mol iii site2.025No Opinion
A pleasure dactions. Hopefully many more positive articles to comes. As Olav says....exosomes are their gold dust....and not valued in a y of the share price forecasts!
Thu 07:48dactionsRE: Exosomes c/o mol iii site2.025No Opinion
Thank you Freddie - first time I've personally seen this specific mention of Reneron's work:
Below extracted from your link:

Quote: And UK-based AIM-listed stem cell therapeutics company ReNeuron plans to exploit exosomes£ ability to easily access parts of the body other drug types struggle to reach. They are developing an exosome-based drug for glioblastoma multiforme (GBM), a difficult to treat brain cancer where patients currently have a median life expectancy of just 12-15 months… Read More
Wed 07:14Fredd1eboyExosomes c/o mol iii site2.05No Opinion
apparently being developed by exopharm - currently a private aus company but hoping to list

http://exopharm.com/

however we do get a mention here

http://exopharm.com/news/2017/10/12/investor-guide/

copied below - mind we are at the tail end

Investors in biotechnology are like two-headed beings £ interested in exceptional financial returns, as well as in ground-breaking innovations that will improve the health of their loved ones.

The Nasdaq Biotech Index has grown 145%… Read More
Tue 21:08Fredd1eboyRead if you want to get really exci2.05No Opinion
Tue 07:58Fredd1eboyRE: Freddie2.10No Opinion
Hi drax. Let's hope for a change in heart. Keep well and thanks for reply. Best wishes. Freddie
Tue 07:46draxFreddie2.075No Opinion
That must be pretty decent vino!

Your overall sentiment is of course spot on but these people struggle with vision beyond the end of their noses.

They live in a world of never-ending today's, a life devoid of tomorrow, next week, next month or year.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Reneuron (RENE) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.